Mannose-binding lectin (MBL) mediates protection against infections by using the complement system, but certain microorganisms may increase infectivity by exploiting this host defense system. Thus, it has been speculated whether genetically determined low MBL levels may confer partial protection against certain intracellular microorganisms, such as Mycobacterium tuberculosis. We investigated MBL alleles in 109 culturepositive human immunodeficiency virus-uninfected patients with tuberculosis living in Denmark and 250 white control subjects. Patients and control subjects were divided into 3 different groups defined by undetectable, low, and high serum MBL concentrations, which correlates to deficient, low, and high expressing MBL genotypes. A significantly decreased frequency of patients with the low-expressing MBL genotype was observed in white patients compared to control subjects. The same tendency also was observed in patients of other ethnic origin. It may be hypothesized that heterozygosity for MBL variant alleles, which encodes low serum MBL levels, is associated with protection against clinical tuberculosis.
Tuberculosis (TB) has a long history and still is a major infectious disease in most parts of the world. However, only 1 of 10 patients infected with Mycobacterium tuberculosis develop clinical disease [1] . Thus, it is assumed that susceptibility for and progression to clinical TB is partly controlled by genetics [2, 3] . This view is consistent with several animal models of TB [4] [5] [6] . Several specific candidate genes, such as natural resistanceassociated macrophage protein 1 (Nramp1 or Slc11a1), vitamin D receptor (VDR), HLA DR2, and mannosebinding lectin (MBL), have been suggested to contribute either to susceptibility or protection against TB in humans [2, 7, 8] .
MBL is an important part of innate immunity and acts in concert with the complement system to opsonize and facilitate phagocytosis of microorganisms [9] . MBL binds to high mannose and N-acetylglucosamine oligosaccharides present in a variety of microorganisms, including M. tuberculosis. For mycobacteria, MBL binds to mannose residues in the lipoarabinomannan membrane (LAM) covering the bacteria [10] .
The MBL gene (mbl2) is located on chromosome 10. Low levels of functional serum MBL are caused by 3 variant alleles (allele B [codon 54], allele C [codon 57], and allele D [codon 52], respectively) in exon 1, causing amino acid changes that disrupt the collagenous backbone of the MBL molecule [11] , leading to a dysfunctional protein. The normal wild-type allele is commonly designated A, and the 3 variant alleles are designated 0. The variant alleles reduce the amount of functional MBL by a factor of 5-10 in heterozygotes, whereas virtually no functional MBL can be detected in homozygous variant allele carriers. Furthermore, the MBL concentrations are independently influenced by a number of nucleotide substitutions in the promoter region of the mbl2 gene. Particularly, a base-pair substitution in codon Ϫ221 (GrC substitution), changing the promoter polymorphism from Y to X, has a profound down-regulating effect on the serum MBL level [11] .
MBL variant alleles have been associated with in- creased risk of infection in children [12] [13] [14] , as well as in adults with concomitant diseases [15] [16] [17] [18] . Moreover, an increased risk toward specific microorganisms (e.g., invasive Streptococcus pneumonia) also has been indicated [19] .
The variant alleles have been observed with high frequency in several populations. Thus, it has been suggested that they confer relative advantages for the host and represent a balanced genetic system [20] [21] [22] . Intracellular microbes, such as M. tuberculosis and Leishmania species, partly use opsonization by the complement system and thus probably MBL to enter host cells [23] . One of the hypotheses that have been put forward to explain why MBL variant alleles have reached such a high frequency in different populations is the possible advantage that low MBL levels reduces the amount of complement deposited on the surface of intracellular pathogens, which exploits complement and complement receptors (CRs) to invade and replicate in host cells [10, 21] .
Several studies have indicated a partial protective effect of heterozygosity for MBL variant alleles against TB [2, 24, 25] , whereas others have pointed toward an increased susceptibility for TB for homozygous carriers of MBL variant alleles [26] . To further elucidate whether MBL might be involved in the pathophysiology of clinical TB, we investigated MBL alleles in human immunodeficiency virus (HIV)-uninfected white and nonwhite patients with TB, as well as white control subjects living in Denmark.
PATIENTS AND METHODS
Patients. During 1997-2001, blood samples were collected at the Department of Pulmonary Medicine and Department of Infectious Medicine, Rigshospitalet (Copenhagen), from 109 patients with culture-positive TB living in Denmark, drawn in EDTA-stabilized tubes and serum tubes, respectively. The patients included 59 whites, 26 Asians, 17 Africans, and 7 Inuits (table 1). All patients were unrelated and were HIV uninfected.
Data, including culture and microscopy results for M. tuberculosis, were obtained from each patient from the International Reference Laboratory of Mycobacteriology at Statens Serum Institut (Copenhagen). Patients were either culture positive or microscopy and culture positive. Demographic data, including age, sex, and ethnic origin, were collected from the patients' medical records (table 1) . A total of 250 healthy unrelated Danes served as control subjects; this population comprised 190 blood donors and 60 members of the laboratory staff [27] . All patients received both verbal and written information and provided signed informed consent. The study protocol was accepted by the Danish Central Ethical Committee (NR:KFO1-274/99).
Detection of MBL serum concentration and genotypes. MBL concentrations were measured in available sera from patients (101 [93%] serum samples available from 109 patients) in a double-enzyme immunoassay, as described elsewhere [20] . Genomic DNA was isolated from whole EDTA blood according to a standard procedure [28] . DNA was amplified via sequencespecific polymerase chain reaction (PCR; SSP), and the MBL alleles were detected as described elsewhere [11] . MBL genotypes were divided into groups describing their variant alleles B, C, and D. All 3 variant alleles were pooled together as allele 0 to avoid small groups (table 2). On the basis of these genotypes and the effect of the promoter variant in position Ϫ221 on the MBL serum concentration, 6 MBL genotypes were defined [29] . The A/A group comprised 2 normal structural alleles with high-expression promoter activity (YA/YA), 1 high-expression and one low-expression promoter (YA/XA), and 2 lowexpression promoter alleles (XA/XA). The A/0 group comprised 1 variant allele (i.e., defective allele) and 1 normal allele combined with a high (YA/0) or low-expression promoter (XA/0). The 0/0 group comprised 2 defective structural alleles. Moreover, we pooled the patients into 3 groups according to the MBL serum levels-high MBL levels (genotypes YA/YA, YA/XA, Figure 1 . Mannose-binding lectin (MBL) concentration in serum (mg/L) and the corresponding the 6 MBL genotypes defined by variant MBL alleles and promotor alleles from patients with tuberculosis. The box plot shows the 10th, 25th, 50th, 75th, and 90th percentiles. The difference between the groups was highly significant ( ). P ! .0001 
RESULTS
The patients included 59 whites, 17 Africans, 26 Asians, and 7 Inuits. There was no difference in mean age at time of diagnosis between the ethnic groups (table 1). The correlation between the MBL serum concentrations and the MBL genotypes is shown in figure 1 ( ). P ! .0001 Functional MBL could not be detected in serum samples from patients with the 0/0 genotype (detection limit in the assay is 20 mg/L), whereas patients with 1 normal structural A allele with 1 low-expression promoter allele in combination with a defective 0 allele (XA/0) produced small but significant amounts of functional MBL. Conversely, higher concentrations of functional MBL could be detected in serum samples from persons carrying the other genotypes (YA/YA, YA/XA, XA/XA, and YA/0) (figure 1).
Comparing structural MBL alleles in white patients and control subjects (table 2) revealed no overall significant difference between genotype A/A, A/0, and 0/0. Table 3 shows the distributions of MBL structural and promoter alleles divided by patients and control subjects. When including the promoter polymorphisms according to high MBL (YA/YA, YA /XA, XA/ XA, and YA/0), low MBL (XA/0), and deficient MBL (0/0), a significant difference in genotype frequency ( ) was re-P p .03 vealed. The main contribution to the significant P value is due to extreme low frequency of genotypes corresponding to low serum MBL (XA/0) in patients versus matched control subjects (3% vs. 13%, respectively). The same tendency was seen for the patients with other ethnic backgrounds. The significance of this result also was revealed when selectively comparing genotypes corresponding to high MBL (YA/YA, YA/XA, XA/XA, and YA/0) and low serum MBL (XA/0) ( ), as well as P p .03 when comparing the genotypes corresponding to low (XA/0) and deficient (0/0) MBL serum levels ( ) (table 4) . No P p .01 association was observed between the presence of variant alleles and the presence of pulmonary cavities ( ). P p .87
DISCUSSION
MBL variant alleles and thereby decreased serum MBL levels are surprisingly frequent in different populations, although variant alleles levels are associated with increased risk and/or severity of different types of infections [13] [14] [15] 32] . Two main hypotheses have been put forward to explain this phenomenon. First, MBL binding to certain microorganisms may under some circumstances lead to uncontrolled complement activation, which, in some situations, may be deleterious for the host [20, 22] . Support for this view comes from a recent mouse MBL knockout model indicating that mice partly lacking MBL may, to some extent, be protected against death in a septic peritonitis model [33] . Second, the presence of variant alleles is promoted, because many intracellular pathogens exploits deposition of complement on the surface to amplify uptake of the microorganism in phagocytes by CRs [21] . This hypothesis has gained support from several epidemiological observations showing that low MBL levels (i.e., heterozygosity) may be protective against clinical TB in African patients without HIV and also against visceral leishmaniasis [23] [24] [25] . By contrast, it has been shown that homozygosity for the MBL variant allele indeed may promote mycobacterial infection in patients with TB from India [26] and also in Danish patients with atypical mycobacterial infection and AIDS [15] .
In the present study, we have investigated whether variation in the MBL gene may be associated with clinical TB in patients living in a western urban setting. The present results show that the frequency of a low promoter allele in front of a normal mbl2 gene on one chromosome and a dysfunctional structural allele on the other (XA/0) is significantly decreased in white patients with TB compared with matched control subjects. The MBL genotypes and serum MBL are highly significantly correlated (figure 1), which suggests that low serum MBL concentrations may be protective against TB. The same was observed in a population of immigrants living in Denmark, in which no matched control subjects were available. These observations are fully compatible with the above-mentioned notion that both high levels of MBL, as well as MBL deficiency, may confer increased risk of clinical TB. Thus, although this observation is not a classical heterosis situation (i.e., heterozygous advantage as seen with HbS allele in malaria and sicklecell anemia), it indicates that individuals heterozygous for a structural variant allele who also carry a low-expression promoter in front of the normal allele on the other chromosome are partly protected against clinical TB.
In figure 2 , we have summarized 3 different scenarios that may be used as a working hypothesis to explain our results. In the hypothesis, a key role of the mannose receptor (MR) on macrophages is suggested. The MR, along with CRs, mediates phagocytosis in vitro of virulent M. tuberculosis strains [34] . LAM on the surface of the M. tuberculosis is ligand for both the MR and MBL, and they might compete for the same binding sites [35] . Scenario 1 illustrates how high MBL levels may mediate complement activation and uptake of M. tuberculosis by CRs on macrophage bypassing the MR-mediated uptake. Scenario 2 illustrates that low MBL levels may not lead to complement activation [36] ; instead, MBL may compete with MR for the same binding sites on M. tuberculosis and thus may inhibit the uptake of the bacteria in the host cells. Scenario 3 illustrates how MBL deficiency may lead to direct uptake of M. tuberculosis by MR [26, 34, 37] . The model in figure 2 is of course oversimplified and does not take into account the possible modifying effect of MBL on different cytokines and T cells. For example, studies have shown that ligation of CR 3 (CD11b) to complement C3b on various microorganisms selectively suppress the interleukin-12 response from the macrophage, an important mediator of the cellular immune response to M. tuberculosis [38, 39] . Nevertheless, this hypothesis may be a basis for an experimental approach, which can be further tested in vitro and in vivo.
It is pertinent to ask whether our and previous observations in this field reflect protection against direct transmission or is related to protection against clinical TB per se. In the present study, only M. tuberculosis culture-positive patients were included. In previous studies, MBL seemed to enhance the occurrence of tuberculous meningitis [25] . Because MBL is almost absent in uninfected lungs and appears on the scene with considerable delay after an infectious challenge [40] , we wonder whether MBL is more associated with development of clinical TB rather than enhancement of the primary uptake of M. tuberculosis in alveolar macrophages.
Another question is whether the mbl2 gene is the primary locus of the observed association or whether linkage disequilibrium to another gene on chromosome 10 is responsible for the observed differences. Two candidate genes that could be implicated are the genes coding for the lung surfactant proteins SP-A and SP-D. Both are polymorphic and located in the vicinity of the mbl2 gene [41] . SP-A and SP-D have in several studies been shown to be involved in the pathophysiology of the immune response to M. tuberculosis [42] [43] [44] . However, the observation between MBL alleles and TB relies on combination of different alleles, which indicates that this may be the primary association and not a secondary one attributable to linkage disequilibrium.
In conclusion, we found that a low-expression MBL genotype XA/0 may be associated with protection against TB, whereas high-expression genotypes and genotypes conferring MBL deficiency are not. This supports previous suggestions that the MBL genetic system may play a dual role in host defense even in the same disease entity, which may in part explain the high frequency of MBL alleles in different populations throughout the world.
